Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Chronic weight management
Humanistic burden and health-related quality of life
8 evidence topics · 7 sources
Obesity and health-related quality of life: systematic review of reviews
“We found that in all populations, obesity was associated with significantly lower generic and obesity‐specific HRQoL.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“in population data from six countries the relationship between BMI and SF‐36 PCS was dose‐dependent, with poorer physical HRQoL occurring in those with higher BMIs, whereas MCS scores were reduced only in those with Class III obesity.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Improved HRQoL was evident after non‐surgical weight loss, but was not consistently demonstrated, even in randomized controlled trials.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Obesity and health-related quality of life: updated systematic review of reviews
“In total, eight SLRs and/or meta‐analyses published since 2017 were identified. The results consistently demonstrated a negative association between obesity and HRQoL, with some evidence suggesting poorer HRQoL in people with adverse metabolic profiles.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Notably, no SLRs on anti‐obesity medications were identified, limiting conclusions on this emerging treatment area.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Patient-reported impacts of excess weight in qualitative interviews
“Participants consistently reported that excess weight limited physical activity and comfort, energy/stamina and self‐confidence/self‐esteem. Impacts on emotional, social and sexual functioning, as well as productivity and overall health, were also reported.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
SF-12 physical and mental component scores by BMI class in U.S. adults
“Higher BMI was associated with significantly lower scores on both SF‐12 PCS and MCS (Table 3). The median PCS score was 55.86 for NW respondents, while respondents with OW, C1, C2 and C3 obesity had a median PCS score of 54.52, 52.83, 51.28, and 47.21, respectively (p < 0.001). The median MCS score for respondents who were NW, OW, C1, C2, and C3 obesity was 54.74, 54.96, 54.59, 54.20, and 52.41, respectively (p < 0.001) (Table 3).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The proportion of respondents who reported an inability to work increased significantly (p < 0.001) with increasing BMI category (NW: 10.3%; OW: 11.2%; C1: 14.6%; C2: 17.8%; C3: 26.9%) (Table 3).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
SF-36v2, work productivity, and patient activation by BMI class in the National Health and Wellness Survey
“In the overall population of 69,742 adult respondents with BMI ≥18.5kg/m2, a lower proportion of older adults were classified as class 2/3 obesity than those <65y (Table 1)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Overall, as BMI increased people had greater negative effects on HRQoL, felt less involved with and in control of their healthcare, and had greater work productivity and activity impairments. The largest declines were generally observed between class 2 and 3 obesity categories.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“People with T2DM and obesity tended to have greater declines in physical functioning and more work and activity impairments than people with obesity without T2DM.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Utility decrement per unit of BMI used in the ICER model
Weight stigma, bias, and patient-reported experience of care
Change in physical functioning and weight-related quality of life with a GLP-1 receptor agonist
“At Week 68, a greater proportion of participants treated with semaglutide 2.4 mg than with placebo reached meaningful within-person change (MWPC) thresholds for IWQOL-Lite-CT Physical Function scores in STEP 1 (51.8% vs. 28.3%; p < 0.0001) and STEP 2 (39.6% vs. 29.5%; p = 0.0083)” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Semaglutide 2.4 mg significantly improved physical functioning, with greater proportions of participants achieving MWPC compared with placebo, and showed beneficial effects on WRQOL and HRQOL beyond physical functioning.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote